| Saham Orang Dalam | 12,988,695 shares |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
N/A
Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
N/A
Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di PHGE.U / BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di PHGE.U / BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder t. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
| Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-21 | 2025-04-14 | 4/A | Bassan Merav | PHGE | Common Stock | D | 79,597 | 79,597 | ||||||
| 2025-04-21 | 2025-04-14 | 4/A | Solomon Jonathan Eitan | PHGE | Common Stock | D | 126,748 | 126,748 | ||||||
| 2025-04-21 | 2025-04-14 | 4/A | Wolfson Marina | PHGE | Common Stock | D | 68,545 | 68,545 | ||||||
| 2025-04-18 | 2025-04-14 | 4 | Solomon Jonathan Eitan | PHGE | Common Stock | D | 126,748 | 126,748 | ||||||
| 2025-04-18 | 2025-04-14 | 4 | Bassan Merav | PHGE | Common Stock | D | 79,597 | 79,597 | ||||||
| 2025-04-18 | 2025-04-14 | 4 | Wolfson Marina | PHGE | Common Stock | D | 68,545 | 68,545 | ||||||
| 2025-03-04 | 2024-07-15 | 5 | Cystic Fibrosis Foundation | PHGE | Common Stock, par value $0.0001 per share | D | 854,700 | 1,787,758 | ||||||
| 2025-03-03 | 2025-02-27 | 4 | Flynn James E Through Deerfield Healthcare Innovations Fund II, L.P. | PHGE | Common Stock | I | 0.9306 | 353,249 | 329 | 1,247,054 | ||||
| 2025-03-03 | 2025-02-27 | 4 | Flynn James E Through Deerfield Private Design Fund V, L.P. | PHGE | Common Stock | I | 0.9306 | 353,249 | 329 | 1,247,054 | ||||
| 2024-09-18 | 2024-09-16 | 4 | Bassan Merav | PHGE | Common Stock | D | 31,749 | 31,749 | ||||||
| 2024-09-18 | 2024-09-16 | 4 | Oron Assaf | PHGE | Common Stock | D | 25,804 | 25,804 | ||||||
| 2024-09-18 | 2024-09-16 | 4 | Solomon Jonathan Eitan | PHGE | Common Stock | D | 50,556 | 53,056 | ||||||
| 2024-07-17 | 2024-07-15 | 4 | Flynn James E Through Deerfield Private Design Fund V, L.P. | PHGE | Common Stock | I | 5,883,000 | 8,938,049 | ||||||
| 2024-07-17 | 2024-07-15 | 4 | Flynn James E Through Deerfield Healthcare Innovations Fund II, L.P. | PHGE | Common Stock | I | 5,883,000 | 8,938,049 | ||||||
| 2024-05-20 | 2024-05-15 | 4 | OrbiMed Israel BioFund GP Limited Partnership See footnotes | PHGE | Common Stock | I | 0.3812 | -24,344 | -9 | 13,773,653 | ||||
| 2024-05-20 | 2024-05-15 | 4 | OrbiMed Israel BioFund GP Limited Partnership See footnotes | PHGE | Common Stock | I | 0.2440 | 9,280,408 | 2,264 | 13,797,997 | ||||
| 2024-05-17 | 2024-05-15 | 4 | Cystic Fibrosis Foundation | PHGE | Common Stock, par value $0.0001 per share | D | 0.0010 | 4,778,265 | 5 | 9,330,580 | ||||
| 2024-03-26 | 3 | Cystic Fibrosis Foundation | PHGE | Common Stock, par value $0.0001 per share | D | 4,552,315 | ||||||||
| 2024-03-19 | 2024-03-15 | 4 | Flynn James E Through Deerfield Healthcare Innovations Fund II, L.P. | PHGE | Common Stock | I | 3,055,049 | 3,055,049 | ||||||
| 2024-03-19 | 2024-03-15 | 4 | Flynn James E Through Deerfield Private Design Fund V, L.P. | PHGE | Common Stock | I | 3,055,049 | 3,055,049 | ||||||
| 2023-12-01 | 2023-11-29 | 4 | Oron Assaf | PHGE | Common Stock | D | 0.3400 | -2,056 | -1 | 0 | ||||
| 2023-12-01 | 2023-11-29 | 4 | Oron Assaf | PHGE | Common Stock | D | 0.3500 | -3,414 | -1 | 2,056 | ||||
| 2023-12-01 | 2023-11-29 | 4 | Oron Assaf | PHGE | Common Stock | D | 0.4000 | -5,444 | -2 | 5,470 | ||||
| 2023-05-24 | 2023-05-22 | 4 | Oron Assaf | PHGE | Common Stock | D | 0.2731 | 3,192 | 1 | 10,914 | ||||
| 2023-05-22 | 2023-05-19 | 4 | Oron Assaf | PHGE | Common Stock | D | 0.2809 | 6,521 | 2 | 7,722 | ||||
| 2023-05-22 | 2023-05-18 | 4 | Oron Assaf | PHGE | Common Stock | D | 0.2727 | 1,201 | 0 | 1,201 | ||||
| 2023-03-17 | 2023-02-27 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock | I | 0.2450 | 348,000 | 85 | 3,161,489 | ||||
| 2022-11-14 | 2022-11-04 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3780 | -1,501 | -1 | 2,997,025 | ||||
| 2022-11-14 | 2022-11-03 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3660 | -2,000 | -1 | 2,998,526 | ||||
| 2022-11-14 | 2022-11-02 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3590 | -2,416 | -1 | 3,000,526 | ||||
| 2022-11-14 | 2022-11-01 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3640 | -1,300 | -0 | 3,002,942 | ||||
| 2022-11-14 | 2022-10-31 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3710 | -3,300 | -1 | 3,004,242 | ||||
| 2022-11-14 | 2022-10-28 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3560 | -1,526 | -1 | 3,007,542 | ||||
| 2022-11-14 | 2022-10-27 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3640 | -1,505 | -1 | 3,009,068 | ||||
| 2022-11-14 | 2022-10-26 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3460 | -12,500 | -4 | 3,010,573 | ||||
| 2022-11-14 | 2022-10-25 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3650 | -3,072 | -1 | 3,023,073 | ||||
| 2022-11-14 | 2022-10-24 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3490 | -5,900 | -2 | 3,026,145 | ||||
| 2022-11-14 | 2022-10-21 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3700 | -5,400 | -2 | 3,032,045 | ||||
| 2022-11-14 | 2022-10-20 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3740 | -6,636 | -2 | 3,037,445 | ||||
| 2022-11-14 | 2022-10-19 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3670 | -4,501 | -2 | 3,044,081 | ||||
| 2022-11-14 | 2022-10-18 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3460 | -15,300 | -5 | 3,048,582 | ||||
| 2022-11-14 | 2022-10-17 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3350 | -8,098 | -3 | 3,063,882 | ||||
| 2022-11-14 | 2022-10-14 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3310 | -3,420 | -1 | 3,071,980 | ||||
| 2022-11-14 | 2022-10-13 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3300 | -11,314 | -4 | 3,075,400 | ||||
| 2022-11-14 | 2022-10-12 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3330 | -9,700 | -3 | 3,086,714 | ||||
| 2022-11-14 | 2022-10-11 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3320 | -5,988 | -2 | 3,096,414 | ||||
| 2022-11-14 | 2022-10-10 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3260 | -10,043 | -3 | 3,102,402 | ||||
| 2022-11-14 | 2022-10-07 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3580 | -24,708 | -9 | 3,112,445 | ||||
| 2022-11-14 | 2022-10-06 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.4440 | -25,098 | -11 | 3,137,153 | ||||
| 2022-11-14 | 2022-10-05 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.4350 | -46,785 | -20 | 3,162,251 | ||||
| 2022-11-14 | 2022-10-04 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3440 | -19,200 | -7 | 3,209,036 | ||||
| 2022-11-14 | 2022-10-03 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3300 | -15,022 | -5 | 3,228,236 | ||||
| 2022-11-14 | 2022-09-30 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3560 | -8,662 | -3 | 3,243,258 | ||||
| 2022-11-14 | 2022-09-29 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3490 | -3,300 | -1 | 3,251,920 | ||||
| 2022-11-14 | 2022-09-28 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3330 | -15,649 | -5 | 3,255,220 | ||||
| 2022-11-14 | 2022-09-27 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3310 | -4,866 | -2 | 3,270,869 | ||||
| 2022-11-14 | 2022-09-26 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3550 | -17,528 | -6 | 3,275,735 | ||||
| 2022-11-14 | 2022-09-23 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.3740 | -5,306 | -2 | 3,293,263 | ||||
| 2022-11-14 | 2022-09-22 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.4130 | -17,388 | -7 | 3,298,569 | ||||
| 2022-11-14 | 2022-09-21 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.4270 | -5,574 | -2 | 3,315,957 | ||||
| 2022-11-14 | 2022-09-20 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.4510 | -10,626 | -5 | 3,321,531 | ||||
| 2022-11-14 | 2022-09-19 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.4850 | -13,870 | -7 | 3,332,157 | ||||
| 2022-11-14 | 2022-09-16 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.5130 | -3,200 | -2 | 3,346,027 | ||||
| 2022-11-14 | 2022-09-15 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.5310 | -3,900 | -2 | 3,349,227 | ||||
| 2022-11-14 | 2022-09-14 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.5230 | -2,301 | -1 | 3,353,127 | ||||
| 2022-11-14 | 2022-09-13 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.5250 | -2,201 | -1 | 3,335,428 | ||||
| 2022-11-14 | 2022-09-12 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.5410 | -1,700 | -1 | 3,357,629 | ||||
| 2022-11-14 | 2022-09-09 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.5180 | -13,219 | -7 | 3,359,329 | ||||
| 2022-11-14 | 2022-09-08 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.5220 | -4,592 | -2 | 3,372,548 | ||||
| 2022-11-14 | 2022-09-07 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.5280 | -8,846 | -5 | 3,377,140 | ||||
| 2022-11-14 | 2022-09-06 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.5450 | -6,403 | -3 | 3,385,986 | ||||
| 2022-11-14 | 2022-09-02 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.5460 | -2,001 | -1 | 3,392,389 | ||||
| 2022-11-14 | 2022-09-01 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.5460 | -8,297 | -5 | 3,394,390 | ||||
| 2022-11-14 | 2022-08-31 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.5490 | -4,540 | -2 | 3,402,687 | ||||
| 2022-11-14 | 2022-08-30 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.5660 | -13,487 | -8 | 3,407,227 | ||||
| 2022-11-14 | 2022-08-29 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.5710 | -11,533 | -7 | 3,420,714 | ||||
| 2022-11-14 | 2022-08-26 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.6160 | -60,628 | -37 | 3,432,247 | ||||
| 2022-11-14 | 2022-08-25 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.7180 | -26,945 | -19 | 3,492,875 | ||||
| 2022-11-14 | 2022-08-24 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.6520 | -8,665 | -6 | 3,519,820 | ||||
| 2022-11-14 | 2022-08-23 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.6380 | -5,900 | -4 | 3,528,485 | ||||
| 2022-11-14 | 2022-08-22 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.6570 | -5,000 | -3 | 3,534,385 | ||||
| 2022-11-14 | 2022-08-19 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.6390 | -14,600 | -9 | 3,539,385 | ||||
| 2022-11-14 | 2022-08-18 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.6830 | -7,764 | -5 | 3,553,985 | ||||
| 2022-11-14 | 2022-08-17 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.6880 | -21,335 | -15 | 3,561,749 | ||||
| 2022-11-14 | 2022-08-16 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.7290 | -8,563 | -6 | 3,583,084 | ||||
| 2022-11-14 | 2022-08-15 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.7470 | -7,200 | -5 | 3,591,647 | ||||
| 2022-11-14 | 2022-08-12 | 4 | Ugwumba Chidozie By Symbiosis, LLC | PHGE | Common Stock | I | 0.7340 | -11,406 | -8 | 3,598,847 | ||||
| 2022-11-14 | 2022-08-11 | 4 | Ugwumba Chidozie By Symbiosis, LLC | PHGE | Common Stock | I | 0.7440 | -9,824 | -7 | 3,610,253 | ||||
| 2022-11-14 | 2022-08-10 | 4 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 0.7400 | -17,769 | -13 | 3,620,077 | ||||
| 2022-03-31 | 2022-03-29 | 4 | GROSSMAN JONAS | PHGE | Common Stock Options - Right to Buy | D | 1.41 | 20,500 | 20,500 | |||||
| 2022-03-31 | 2022-03-29 | 4 | Sullivan Lynne Marie | PHGE | Common Stock Options - Right to Buy | D | 1.41 | 20,500 | 20,500 | |||||
| 2022-03-31 | 2022-03-29 | 4 | Amusa Gbolahan | PHGE | Common Stock Options - Right to Buy | D | 1.41 | 20,500 | 20,500 | |||||
| 2022-03-31 | 2022-03-29 | 4 | Greig Russell | PHGE | Common Stock Options - Right to Buy | D | 1.41 | 41,000 | 41,000 | |||||
| 2022-03-31 | 2022-03-29 | 4 | Wolfson Marina | PHGE | Common Stock Options - Right to Buy | D | 1.41 | 50,000 | 50,000 | |||||
| 2022-03-31 | 2022-03-29 | 4 | Solomon Jonathan Eitan | PHGE | Common Stock Options - Right to Buy | D | 1.41 | 205,000 | 205,000 | |||||
| 2022-03-31 | 2022-03-29 | 4 | Bassan Merav | PHGE | Common Stock Options - Right to Buy | D | 1.41 | 100,000 | 100,000 | |||||
| 2022-03-31 | 2022-03-29 | 4 | Moses Alan Charles | PHGE | Common Stock Options - Right to Buy | D | 1.41 | 20,500 | 20,500 | |||||
| 2022-02-14 | 2021-12-31 | 4 | Walton Thomas Layton By SymBiosis, LLC | PHGE | Warrants to purchase Common Stock | I | 5.00 | -1,875,000 | 0 | |||||
| 2022-02-14 | 2021-12-31 | 4 | Walton Thomas Layton By SymBiosis, LLC | PHGE | Common Stock, $0.0001 par value | I | -3,637,846 | 0 | ||||||
| 2022-02-14 | 3 | Ugwumba Chidozie By SymBiosis, LLC | PHGE | Common Stock | I | 3,637,846 | ||||||||
| 2021-08-17 | 2021-07-26 | 4/A | GROSSMAN JONAS | PHGE | Common Stock, par value $0.0001 | D | 37,500 | 372,717 | ||||||
| 2021-08-17 | 2020-07-26 | 4/A | GROSSMAN JONAS | PHGE | Warrants to purchase Common Stock | D | 5.00 | 28,125 | 28,125 | |||||
| 2021-08-09 | 3 | Walton Thomas Layton By SymBiosis, LLC | PHGE | Common Stock, $0.0001 par value | I | 3,637,846 | ||||||||
| 2021-07-30 | 2021-07-28 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Warrants (Right to Buy) | I | 5.00 | 375,000 | 375,000 | |||||
| 2021-07-30 | 2021-07-28 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock, $0.0001 par value | I | 500,000 | 2,813,489 | ||||||
| 2021-07-30 | 2021-07-28 | 4 | Wolfson Marina | PHGE | Common Stock Warrant | D | 5.00 | 2,813 | 2,813 | |||||
| 2021-07-30 | 2021-07-28 | 4 | Wolfson Marina | PHGE | Common Stock | D | 4.0000 | 3,750 | 15 | 3,750 | ||||
| 2021-07-30 | 2021-07-28 | 4 | Sullivan Lynne Marie | PHGE | Common Stock Warrant | D | 5.00 | 9,375 | 9,375 | |||||
| 2021-07-30 | 2021-07-28 | 4 | Sullivan Lynne Marie | PHGE | Common Stock | D | 4.0000 | 12,500 | 50 | 12,500 | ||||
| 2021-07-30 | 2021-07-28 | 4 | Solomon Jonathan Eitan | PHGE | Common Stock Warrant | D | 5.00 | 18,750 | 18,750 | |||||
| 2021-07-30 | 2021-07-28 | 4 | Solomon Jonathan Eitan | PHGE | Common Stock | D | 4.0000 | 25,000 | 100 | 25,000 | ||||
| 2021-07-30 | 2021-07-28 | 4 | SEKHRI PAUL J | PHGE | Common Stock Warrant | D | 5.00 | 9,375 | 9,375 | |||||
| 2021-07-30 | 2021-07-28 | 4 | SEKHRI PAUL J | PHGE | Common Stock | D | 4.0000 | 12,500 | 50 | 12,500 | ||||
| 2021-07-30 | 2021-07-28 | 4 | Greig Russell | PHGE | Common Stock Warrant | I | 5.00 | 2,813 | 2,813 | |||||
| 2021-07-30 | 2021-07-28 | 4 | Greig Russell | PHGE | Common Stock | I | 4.0000 | 3,750 | 15 | 3,750 | ||||
| 2021-07-30 | 2021-07-28 | 4 | Moses Alan Charles | PHGE | Common Stock Warrant | D | 5.00 | 3,750 | 3,750 | |||||
| 2021-07-30 | 2021-07-28 | 4 | Moses Alan Charles | PHGE | Common Stock | D | 4.0000 | 5,000 | 20 | 5,000 | ||||
| 2021-07-28 | 2021-07-26 | 4 | GROSSMAN JONAS | PHGE | Warrants to purchase Common Stock | D | 5.00 | 28,125 | 28,125 | |||||
| 2021-07-28 | 2021-07-26 | 4 | GROSSMAN JONAS | PHGE | Common Stock, par value $0.0001 | D | 37,500 | 372,217 | ||||||
| 2021-07-28 | 2021-07-26 | 4 | Amusa Gbolahan | PHGE | Warrants to purchase Common Stock | D | 5.00 | 18,750 | 18,750 | |||||
| 2021-07-28 | 2021-07-26 | 4 | Amusa Gbolahan | PHGE | Common Stock, par value $0.0001 | D | 25,000 | 262,871 | ||||||
| 2021-04-01 | 2021-03-30 | 4 | Puttagunta Sailaja | PHGE | Common Stock Options - Right to Buy | D | 7.02 | 71,250 | 71,250 | |||||
| 2021-04-01 | 2021-03-30 | 4 | Greig Russell | PHGE | Common Stock Options - Right to Buy | D | 7.02 | 30,400 | 30,400 | |||||
| 2021-04-01 | 2021-03-30 | 4 | SEKHRI PAUL J | PHGE | Common Stock Options - Right to Buy | D | 7.02 | 15,200 | 15,200 | |||||
| 2021-04-01 | 2021-03-30 | 4 | Oron Assaf | PHGE | Common Stock Options - Right to Buy | D | 7.02 | 33,250 | 33,250 | |||||
| 2021-04-01 | 2021-03-30 | 4 | Moses Alan Charles | PHGE | Common Stock Options - Right to Buy | D | 7.02 | 15,200 | 15,200 | |||||
| 2021-04-01 | 2021-03-30 | 4 | Bassan Merav | PHGE | Common Stock Options - Right to Buy | D | 7.02 | 47,500 | 47,500 | |||||
| 2021-04-01 | 2021-03-30 | 4 | Wolfson Marina | PHGE | Common Stock Options - Right to Buy | D | 7.02 | 33,250 | 33,250 | |||||
| 2021-04-01 | 2021-03-30 | 4 | Sullivan Lynne Marie | PHGE | Common Stock Options - Right to Buy | D | 7.02 | 15,200 | 15,200 | |||||
| 2021-04-01 | 2021-03-30 | 4 | Solomon Jonathan Eitan | PHGE | Common Stock Options - Right to Buy | D | 7.02 | 152,000 | 152,000 | |||||
| 2021-04-01 | 2021-03-30 | 4 | GROSSMAN JONAS | PHGE | Common Stock Options - Right to Buy | D | 7.02 | 15,200 | 15,200 | |||||
| 2021-04-01 | 2021-03-30 | 4 | Amusa Gbolahan | PHGE | Common Stock Options - Right to Buy | D | 7.02 | 15,200 | 15,200 | |||||
| 2020-10-05 | 2020-10-02 | 4 | SEKHRI PAUL J | PHGE | Common Stock Options - Right to Buy | D | 6.44 | 16,000 | 16,000 | |||||
| 2020-10-05 | 2020-10-02 | 4 | Moses Alan Charles | PHGE | Common Stock Options - Right to Buy | D | 6.44 | 16,000 | 16,000 | |||||
| 2020-07-27 | 2020-07-13 | 4 | Amusa Gbolahan | PHGE | Warrants to purchase Common Stock | D | 11.50 | 276,190 | 276,190 | |||||
| 2020-07-27 | 2020-07-13 | 4 | Amusa Gbolahan | PHGE | Common Stock, par value $0.0001 | D | 95,148 | 237,871 | ||||||
| 2020-07-22 | 2020-07-13 | 4 | PROPPER KERRY By Mountain Wood, LLC | PHGE | Warrants to purchase Common Stock | I | 11.50 | -2,900,000 | 0 | |||||
| 2020-07-22 | 2020-07-13 | 4 | PROPPER KERRY | PHGE | Warrants to purchase Common Stock | D | 11.50 | 631,786 | 631,786 | |||||
| 2020-07-22 | 2020-07-13 | 4 | PROPPER KERRY By Mountain Wood, LLC | PHGE | Common Stock, par value $0.0001 | I | -999,058 | 0 | ||||||
| 2020-07-22 | 2020-07-13 | 4 | PROPPER KERRY | PHGE | Common Stock, par value $0.0001 | D | 217,652 | 260,771 | ||||||
| 2020-07-22 | 2020-07-13 | 4 | GROSSMAN JONAS | PHGE | Warrants to purchase Common Stock | D | 11.50 | 666,310 | 716,439 | |||||
| 2020-07-22 | 2020-07-13 | 4 | GROSSMAN JONAS | PHGE | Common Stock, par value $0.0001 | D | 229,545 | 335,217 | ||||||
| 2020-07-22 | 2020-06-18 | 4 | GROSSMAN JONAS By Ravenna LLC | PHGE | Common Stock, par value $0.0001 | I | -45,275 | 0 | ||||||
| 2020-06-12 | 2020-06-10 | 4 | PROPPER KERRY By Mountain Wood, LLC | PHGE | Common Stock, par value $0.0001 | I | 999,058 | 999,058 | ||||||
| 2020-06-12 | 2020-06-10 | 4 | PROPPER KERRY | PHGE | Common Stock, par value $0.0001 | D | 43,119 | 43,119 | ||||||
| 2020-06-12 | 2020-06-10 | 4 | Amusa Gbolahan | PHGE | Common Stock, par value $0.0001 | D | 142,723 | 142,723 | ||||||
| 2020-06-12 | 2020-06-10 | 4 | GROSSMAN JONAS By Ravenna LLC | PHGE | Common Stock, par value $0.0001 | I | 42,275 | 45,275 | ||||||
| 2020-06-12 | 2020-06-10 | 4 | GROSSMAN JONAS By Chardan Investments, LLC | PHGE | Common Stock, par value $0.0001 | I | -1,707,500 | 0 | ||||||
| 2020-06-12 | 2020-06-10 | 4 | GROSSMAN JONAS | PHGE | Common Stock, par value $0.0001 | D | 99,172 | 105,672 | ||||||
| 2020-03-27 | 2020-03-25 | 4 | Solomon Jonathan Eitan | PHGE | Common Stock Options - Right to Buy | D | 6.21 | 144,000 | 144,000 | |||||
| 2020-03-27 | 2020-03-25 | 4 | GROSSMAN JONAS | PHGE | Common Stock Options - Right to Buy | D | 6.21 | 16,000 | 16,000 | |||||
| 2020-03-27 | 2020-03-25 | 4 | Chimovits Erez | PHGE | Common Stock Options - Right to Buy | D | 6.21 | 16,000 | 16,000 | |||||
| 2020-03-27 | 2020-03-25 | 4 | Amusa Gbolahan | PHGE | Common Stock Options - Right to Buy | D | 6.21 | 16,000 | 16,000 | |||||
| 2020-03-27 | 2020-03-25 | 4 | Oron Assaf | PHGE | Common Stock Options - Right to Buy | D | 6.21 | 31,500 | 31,500 | |||||
| 2020-03-27 | 2020-03-25 | 4 | Sullivan Lynne Marie | PHGE | Common Stock Options - Right to Buy | D | 6.21 | 16,000 | 16,000 | |||||
| 2020-03-27 | 2020-03-25 | 4 | Breski Yaron | PHGE | Common Stock Options - Right to Buy | D | 6.21 | 16,000 | 16,000 | |||||
| 2020-03-27 | 2020-03-25 | 4 | Wolfson Marina | PHGE | Common Stock Options - Right to Buy | D | 6.21 | 36,000 | 36,000 | |||||
| 2020-03-27 | 2020-03-25 | 4 | Puttagunta Sailaja | PHGE | Common Stock Options - Right to Buy | I | 6.21 | 67,500 | 67,500 | |||||
| 2020-03-27 | 2020-03-25 | 4 | Greig Russell | PHGE | Common Stock Options - Right to Buy | D | 6.21 | 32,000 | 32,000 | |||||
| 2019-12-30 | 2019-12-20 | 4 | GROSSMAN JONAS | PHGE | Warrants | I | 11.50 | -2,900,000 | 0 | |||||
| 2019-12-20 | 2019-12-19 | 4 | Chimovits Erez See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8.9000 | 3,500 | 31 | 2,313,489 | ||||
| 2019-12-20 | 2019-12-18 | 4 | Chimovits Erez See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8.9300 | 500 | 4 | 2,309,989 | ||||
| 2019-12-20 | 2019-12-19 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8.9000 | 3,500 | 31 | 2,313,489 | ||||
| 2019-12-20 | 2019-12-18 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8.9300 | 500 | 4 | 2,309,989 | ||||
| 2019-12-12 | 2019-12-11 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8.9200 | 5,400 | 48 | 2,309,489 | ||||
| 2019-12-12 | 2019-12-10 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8.7500 | 3,400 | 30 | 2,304,089 | ||||
| 2019-12-12 | 2019-12-11 | 4 | Chimovits Erez See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8.9200 | 5,400 | 48 | 2,309,489 | ||||
| 2019-12-12 | 2019-12-10 | 4 | Chimovits Erez See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8.7500 | 3,400 | 30 | 2,304,089 | ||||
| 2019-12-09 | 2019-12-09 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8.6800 | 6,000 | 52 | 2,300,689 | ||||
| 2019-12-09 | 2019-12-06 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8.0000 | 800 | 6 | 2,294,689 | ||||
| 2019-12-09 | 2019-12-05 | 4 | OrbiMed Israel BioFund GP Limited Partnership See Footnotes | PHGE | Common Stock, $0.001 par value | I | 7.9900 | 3,400 | 27 | 2,293,889 | ||||
| 2019-12-09 | 2019-12-09 | 4 | Chimovits Erez See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8.6800 | 6,000 | 52 | 2,300,689 | ||||
| 2019-12-09 | 2019-12-06 | 4 | Chimovits Erez See Footnotes | PHGE | Common Stock, $0.001 par value | I | 8.0000 | 800 | 6 | 2,294,689 | ||||
| 2019-12-09 | 2019-12-05 | 4 | Chimovits Erez See Footnotes | PHGE | Common Stock, $0.001 par value | I | 7.9900 | 3,400 | 27 | 2,293,889 | ||||
| 2019-11-20 | 2019-11-20 | 4 | GROSSMAN JONAS | PHGE | Common Stock, par value $0.0001 | D | 8.0040 | 1,400 | 11 | 6,500 | ||||
| 2019-11-20 | 2019-11-19 | 4 | GROSSMAN JONAS | PHGE | Common Stock, par value $0.0001 | D | 7.5730 | 4,100 | 31 | 5,100 | ||||
| 2019-11-20 | 2019-11-18 | 4 | GROSSMAN JONAS | PHGE | Warrants | D | 11.50 | 0.5990 | 50,129 | 30 | 50,129 | |||
| 2019-11-20 | 2019-11-18 | 4 | GROSSMAN JONAS | PHGE | Common Stock, par value $0.0001 | D | 6.9890 | 1,000 | 7 | 1,000 | ||||
| 2019-11-07 | 3 | Chimovits Erez See Footnotes | PHGE | Common Stock | I | 4,580,980 | ||||||||
| 2019-11-07 | 3 | Chimovits Erez See Footnotes | PHGE | Common Stock | I | 4,580,980 | ||||||||
| 2019-11-07 | 3 | Chimovits Erez See Footnotes | PHGE | Common Stock | I | 4,580,980 | ||||||||
| 2019-11-07 | 3 | OrbiMed Israel GP Ltd. See Footnotes | PHGE | Common Stock | I | 4,580,980 | ||||||||
| 2019-11-07 | 3 | OrbiMed Israel GP Ltd. See Footnotes | PHGE | Common Stock | I | 4,580,980 | ||||||||
| 2019-11-07 | 3 | OrbiMed Israel GP Ltd. See Footnotes | PHGE | Common Stock | I | 4,580,980 | ||||||||
| 2019-11-07 | 3 | OrbiMed Israel GP Ltd. See Footnotes | PHGE | Common Stock | I | 4,580,980 | ||||||||
| 2019-11-05 | 3 | Takeda Ventures, Inc. | PHGE | Common Stock | I | 4,941,870 | ||||||||
| 2019-11-05 | 3 | Takeda Ventures, Inc. | PHGE | Common Stock | I | 4,941,870 | ||||||||
| 2019-11-05 | 3 | Takeda Ventures, Inc. | PHGE | Common Stock | I | 4,941,870 | ||||||||
| 2019-11-05 | 3 | Takeda Ventures, Inc. | PHGE | Common Stock | I | 4,941,870 | ||||||||
| 2019-09-19 | 3 | MMCAP International Inc. SPC | CHAC | Common Stock | D | 3,400,000 | ||||||||
| 2019-09-19 | 3 | MMCAP International Inc. SPC | CHAC | Common Stock | D | 3,400,000 | ||||||||
| 2019-09-19 | 3 | MMCAP International Inc. SPC | CHAC | Common Stock | D | 3,400,000 | ||||||||
| 2018-12-21 | 3 | Gnedy Elliot | CHAC | Common Stock, par value $0.0001 | D | 15,000 | ||||||||
| 2018-12-21 | 3 | Gnedy Elliot | CHAC | Common Stock, par value $0.0001 | D | 15,000 | ||||||||
| 2018-12-21 | 3 | Gnedy Elliot | CHAC | Common Stock, par value $0.0001 | D | 15,000 | ||||||||
| 2018-12-19 | 2018-12-18 | 4 | GROSSMAN JONAS | CHAC | Warrants | I | 11.50 | 0.4000 | 2,900,000 | 1,160 | 2,900,000 | |||
| 2018-12-14 | 3 | Kusseluk Eric | CHAC | Common Stock, par value $0.0001 | D | 15,000 | ||||||||
| 2018-12-14 | 3 | Kusseluk Eric | CHAC | Common Stock, par value $0.0001 | D | 15,000 | ||||||||
| 2018-12-14 | 3 | Kusseluk Eric | CHAC | Common Stock, par value $0.0001 | D | 15,000 | ||||||||
| 2018-12-14 | 3 | GROSSMAN JONAS | CHAC | Common Stock, par value $0.0001 | I | 3,940,000 | ||||||||
| 2018-12-14 | 3 | GROSSMAN JONAS | CHAC | Common Stock, par value $0.0001 | I | 3,940,000 | ||||||||
| 2018-12-14 | 3 | GROSSMAN JONAS | CHAC | Common Stock, par value $0.0001 | I | 3,940,000 | ||||||||
| 2018-12-14 | 3 | Rossen Matthew | CHAC | Common Stock, par value $0.0001 | D | 15,000 | ||||||||
| 2018-12-14 | 3 | Rossen Matthew | CHAC | Common Stock, par value $0.0001 | D | 15,000 | ||||||||
| 2018-12-14 | 3 | Rossen Matthew | CHAC | Common Stock, par value $0.0001 | D | 15,000 | ||||||||
| 2018-12-14 | 3 | RICE YEHUDA MICHAEL | CHAC | Common Stock, par value $0.0001 | D | 15,000 | ||||||||
| 2018-12-14 | 3 | RICE YEHUDA MICHAEL | CHAC | Common Stock, par value $0.0001 | D | 15,000 | ||||||||
| 2018-12-14 | 3 | RICE YEHUDA MICHAEL | CHAC | Common Stock, par value $0.0001 | D | 15,000 | ||||||||
| 2018-12-14 | 3 | Chardan Investments, LLC | CHAC | Common Stock, par value $0.0001 | D | 3,940,000 | ||||||||
| 2018-12-14 | 3 | Chardan Investments, LLC | CHAC | Common Stock, par value $0.0001 | D | 3,940,000 | ||||||||
| 2018-12-14 | 3 | Chardan Investments, LLC | CHAC | Common Stock, par value $0.0001 | D | 3,940,000 | ||||||||
| 2018-12-14 | 3 | Giroux Richard | CHAC | Common Stock, par value $0.0001 | D | 15,000 | ||||||||
| 2018-12-14 | 3 | Giroux Richard | CHAC | Common Stock, par value $0.0001 | D | 15,000 | ||||||||
| 2018-12-14 | 3 | Giroux Richard | CHAC | Common Stock, par value $0.0001 | D | 15,000 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
